FIND MORE MARIJUANA COVERAGE AT WESTWORD.COM/MARIJUANA MARIJUANA TOKE OF THE TOWN On the Dot BY THOMAS MITCHELL Green Dot Labs had a big year in 2021, but co-founder Dave Malone says that was just the beginning. The Boulder-based cannabis com- pany, already an esteemed player in the extrac- tion game, announced itself as one of Colorado’s top cultivations, releasing a handful of new strains that fl oored cannabis connoisseurs. Blue Froot, Copper Chem, Fortissimo, Lemon Butter Rum. You name them, we smoked them — and couldn’t get them from anywhere else. Last year Green Dot also launched a new line of solventless extracts, the Blue Label, designed to showcase the company’s purest concentrates. The company plans to add more versions of rosin and a solventless vaporizer cartridge to the Blue Label this year; it’s also looking at twelve more strain drops and an expansion into Arizona. We caught up with Malone, who owns and runs Green Dot Labs with his wife, Alana, to see what’s next on the dotted line. Westword: When we last talked in 2020, rosin was defi nitely around, but we hadn’t seen live rosin, cold-cured rosin and the solventless world take off yet. How has rosin’s popularity changed over the last two years? Dave Malone: The data speaks for itself. If you look at the market, how much that seg- ment has grown year over year, it goes to show you that consumers in the premium market are willing to spend more money for a better extract. And I say “better” very loosely, because it’s how you quantify it, and how you perceive it and all the hype that goes around it. However, seeing that there are this many people willing to spend big on this product shows that this market is here to stay. With the emergence of all the new technologies and automation of the process, and the refi nement of making rosin, it’s easier to be more commercially viable. One critical piece about solventless is that 26 there’s a very limited genetic set that goes into it. You look at all the producers around right now, and there’s a lot of redundancy. You see multiple producers making the same stuff, and that’s largely a physiological thing about the plant. The resin structure for certain types of plants are conducive for solventless extrac- tion, but the vast majority are not. So you’re really looking for these diamonds in the rough that can make the process commercially vi- able. Because we were founded on making a solvent-based extract, we have a tremendous amount of data on market applicability and fl avor profi les from that method. When we do solventless extraction, we compare against those numbers, and there’s some pretty glar- ing data points in there. The old saying is, “If you’re not using Cook- ies or Banana strains, you’re washing with tears,” because you’re losing money. It’s a very risky process in extracting these wide varieties of fl owers, because the yields can be so dimin- ished and you’ve lost so much value. That still continues to be a point for a large portion of solventless producers, that limited variety. Has rosin’s upswing taken some shine away from live resin and other extracts? I never hear about diamonds anymore. Of course. There’s no doubt a segment of the live-resin market has made an exodus over to rosin. When you look at a timeline of this, at one point we were trying to make solventless hash look like BHO, or a clean shatter. When the fi rst heat press came out, it resembled shat- ter, and then we took a step further to make it look like a live rosin, sugar, sauce or badder. The fl avor profi les were more complex. And for a while we were all trying to make solvent- less extracts look like BHO extracts, but now you see that solventless extracts aren’t yellow anymore like BHO is. That’s because we’re extracting chlorophyll pigment with solvents, which can bring a yellow appearance. That chlorophyll is biodegradable, so the extracts don’t cure and stay fresh as long because the chlorophyl gets rancid over time. Now we’re trying to make BHO look more like rosin, without that chlorophyl pigment. As a tastemaker in cannabis, how much of what you do with Green Dot Labs is built upon what you think people will like versus what you like? Everything we do with genetics and extrac- tion is very self-serving to me. I regard myself as our biggest critic and our ultimate consumer. I have a tremendous amount of experience in the genetics world, and it’s basically everything we do here. I make fl avors that impress me, and if I’m impressed by it, other people typically follow. That’s how our playbook has gone. We’ve created our little genetics bubble here and are fi nding new unique fl avors after sorting through hundreds of hybrids. We’ve refi ned it all down to seventy plants after looking through thousands. I don’t think many companies have gone to the lengths we have to fi nd these exotic, unique fl avors. We try to stay away from the hyped things in the market and have our own breeding program here. We may use other people’s work and tools as inspiration to create new hybrids, but we typically create our own trail there. What was the motivation behind ramping up the fl ower releases in 2021, and how hard was it to choose what to grow and when to drop it? We wanted to start as a fl ower business. When we fi rst launched Green Dot Labs, we had a dispensary model in mind where we’d primarily sell fl owers. Part of our social media strategy is to show the fl owers that go into our extract and articulate some of the characteristics of them. If you look at Green Dot Labs co-founder Dave Malone. the comment sections, it’s an endless list of people who wanted us to release the fl ower. The demand has been there forever. Unfortunately, it takes a lot of maneuvering to add capacity; our extract lines are largely sold out on a continued basis. We didn’t have the capacity to drop fl owers, but last year we acquired a 30,000-square-foot facility in Denver and retrofi tted and upgraded to our technologically rich cultivation platform. It allows us to produce fl ower going forward. We always viewed fl ower as the most prestigious marker in the entire space, because you can hide some fl ower imperfections in extracts. We have extremely high standards, and if you saw the amount of products that we didn’t release and didn’t meet our standards, your mind might be blown. The new facility is only on halfway right now as we wait for our plant counts to increase. But we’re on the trajectory to drop anywhere form 40 to 80 pounds of fl ower per week going forward. That facility gets genetics from our R&D facility in Boulder, where a lot of our genetics are specifi cally selected for extracts. The fl ower experience doesn’t quite translate, but a great deal of our genetic library was pre- selected for fl ower viability, as well. What are some strains you’ve particularly enjoyed, and what are you excited to release in the future? We’re into branding strains, and all of our strains are created in-house. We tried to get an understanding of what works in the craft industry, where it’s extremely diffi cult to stand out. You look at New Belgium Brewery, and I remember seeing a red bicycle on Fat Tire when I was in college in Louisiana. Now when I see a red bicycle, I can almost taste Fat Tire in my mouth. That brand equity I have to that beer is crazy. We’ve started that process here. We have about sixteen branded strains right now, and another twelve that will be produced over the next year on a month-by- month basis. We’re going to be dropping a new branded strain every month with new, unique profi les, an articulation of characteristics, graphics, merchandise and anything else we can come up with. These strains check boxes that a lot of folks don’t even know need checking, because we apply a different lens to genetics being an extraction business at fi rst. I would say over the last year, my favorite strain has been Blu Froot. It’s one of the most exotic blueberry fl avors you’ll fi nd in cannabis. We’re doing a whole Froot series behind all the different colors, and we’re working on a Purple Froot, Yellow Froot and Red Froot, too. The graphics all look sort of alien, because no fruit on earth smells like these. On the other side, we have the Painter series. In that, we have Picasso, and Dalí is the next one to drop. We also have Garlic Banger, which brings this post-apocalyptic vibe. In that series, we also have Thunderdome and Bio Warfare strains. Those ones are about potency and will really rip your head off. They’re vicious strains. Thunderdome is a real standout, barn-burner of a strain. Do you get more smell and fl avor notes from fl ower or rosin? Personally, I don’t think anything smells better than well-cured fl ower. It’s nice to put your nose in a jar of concentrate, but the depth and complexity of well-cured fl ower, you can get lost in it. It has it all, because you’re not di- luting it through the extraction process, where some things do get left behind. If you nail the fl ower, the extracts will be phenomenal. We’re starting to see popular growers branch into rosin extraction and vice-versa. Is that the logical move for either side? Do fl ower connoisseurs naturally gravitate toward rosin? The barriers to entry in solventless extracts are extremely low. The outlay you need to make a compliant facility is relatively inexpen- sive, so it’s easy for fl ower producers to get into the ever-growing extracts market. There’s a total cost-benefi t analysis to look at for fl ower companies looking to enter extraction, and hydrocarbon outfi ts are extremely expensive and regulated. We kind of started this whole process in the early years and built on it year over year, and it’s created a bit of a gap. Are you still worried about biosynthetic can- nabinoids made from yeast? Or have Delta-8 THC and modifi ed cannabinoids taken that lane? Not yet. I think a lot of the big players are sitting on some technology that they’ll deploy in cannabis once federal legalization comes through. With synthetic cannabinoids, there’s a whole DEA process associated with that, which is a big factor as to why they’re not on the market. But the technology already ex- ists to produce more THC in one hour than the world can produce in a year. It can’t be deployed because the feds don’t like it, but I do believe you’ll see big pharmaceutical companies emerge with these patents. Read the full interview at westword.com/ marijuana. Suggest future interview subjects at [email protected]. JANUARY 27-FEBRUARY 2, 2022 WESTWORD | REAL ESTATE | RENTALS | HEALTH WELLNESS | SERVICES | EMPLOYMENT | ADULT | MUSIC | CLASSIFIED | westword.com COURTESY OF GREEN DOT LABS